Wednesday, January 23, 2019
Authored by Stephanie Viroga
The exposure to medicines during pregnancy have a potential risk of teratogenic effects, to facilitate prescription classifications have been created to advice prescribers. The most popular internationally used is the Food and Drugs Administration one. This classification was based in five categories based on evidence of risk, or no risk in pregnancy controlled and animal studies. Multiple limitations have been described for this classification so in 2015 the FDA stated that regulations for information on risks in pregnancy would be modified with narrative descriptions of drug usage during pregnancy and lactation, adding as a new section the potential reproductive risks for both men and women.
To Read More About This Article Please Click on:
For More Articles in Gynecology and Women’s Health Please Click on:
For More Journals In Juniper Publishers Please Click on:
JUNIPER PUBLISHERS- Journal of Gynecology and Women’s Health Medicine's "Future": Pilot Data from a US Sample Shows S...
Theranostics-The Personalized Medicine has Arrived by Catarine Lima Conti in JOJNHC - Juniper Publishers The combination of the wor...
Geography of Crime and Geographic Information Systems by Ksenija Butorac in JFSCI - Juniper Publishers A link between human ...
Impact of Body Mass Index on Cognitive Attention Function in University Students (NTAB) - Juniper PublishersImpact of Body Mass Index on Cognitive Attention Function in University Students by Aparna Sarkar in Novel Techniques in Arthritis &a...